High incidence of adverse events in healthy volunteers receiving rifampicin and adjusted doses of lopinavir/ritonavir tablets-Reference-Cited by-同舟云学术

High incidence of adverse events in healthy volunteers receiving rifampicin and adjusted doses of lopinavir/ritonavir tablets

Published:2008-05-11 Issue:8 Volume:22 Page:931-935
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Nijland Hanneke MJ,L'homme Rafaëlla FA,Rongen Gerard A,van Uden Peter,van Crevel Reinout,Boeree Martin J,Aarnoutse Rob E,Koopmans Peter P,Burger David M

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference19 articles.

1. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis;Blumberg;Am J Respir Crit Care Med,2003

2. Pharmacokinetic interactions between efavirenz and rifampicin in HIV-infected patients with tuberculosis;Lopez-Cortes;Clin Pharmacokinet,2002

3. Efavirenz 600 mg/day versus efavirenz 800 mg/day in HIV-infected patients with tuberculosis receiving rifampicin: 48 weeks results;Manosuthi;AIDS,2006

4. Pharmacokinetic interaction between nevirapine and rifampicin in HIV-infected patients with tuberculosis;Ribera;J Acquir Immune Defic Syndr,2001

5. Nevirapine plasma concentrations and concomitant use of rifampin in patients coinfected with HIV-1 and tuberculosis;Autar;Antivir Ther,2005

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Antiretroviral Therapy for Patients with Human Immunodeficiency Virus-Associated Tuberculosis;Viruses;2024-03-23

2. Clinical considerations and pharmacokinetic interactions between HIV and tuberculosis therapeutics;Expert Review of Clinical Pharmacology;2024-02-14

3. Drug-Drug and Food-Drug Interactions of Pharmacokinetic Nature;ADME Processes in Pharmaceutical Sciences;2024

4. Pharmacokinetics and Safety of Twice-daily Ritonavir-boosted Atazanavir With Rifampicin;Clinical Infectious Diseases;2023-11-20

5. Activation of PXR causes drug interactions with Paxlovid in transgenic mice;Acta Pharmaceutica Sinica B;2023-11